Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection

AT Obi, GD Barnes, LM Napolitano, PK Henke… - Journal of Vascular …, 2021 - Elsevier
Objective Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
virus confers a risk of significant coagulopathy, with the resulting development of venous
thromboembolism (VTE), potentially contributing to the morbidity and mortality. The purpose
of the present review was to evaluate the potential mechanisms that contribute to this
increased risk of coagulopathy and the role of anticoagulants in treatment. Methods A
literature review of coronavirus disease 2019 (COVID-19) and/or SARS-CoV-2 and cell …
以上显示的是最相近的搜索结果。 查看全部搜索结果